SINOVAC BIOTECH LTD. - Common Shares (SVA)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Shares
Shares outstanding: 71.9M
Number of holders: 16
Total 13F shares, excl. options: 19.9M
Shares change: +3K
Total reported value, excl. options: $450M
Value change: +$19K
Number of buys: 1
Price: $6.47

Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q1 2021

16 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q1 2021.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 19.9M shares of 71.9M outstanding shares and own 27.63% of the company stock.
Largest 10 shareholders include SAIF Advisors Ltd (10.8M shares), Vivo Capital, LLC (5.9M shares), RENAISSANCE TECHNOLOGIES LLC (2.38M shares), Neumann Advisory Hong Kong Ltd (316K shares), STATE STREET CORP (282K shares), Yorktown Management & Research Co Inc (74.9K shares), Skandinaviska Enskilda Banken AB (publ) (40K shares), GEODE CAPITAL MANAGEMENT, LLC (27.7K shares), Eqis Capital Management, Inc. (18.1K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (16.4K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.